A judge has ordered that the lead applicant in a class action against German cladding manufacturer 3A Composites give further details on how its allegedly […]
A judge has signed off on a $44.5 million settlement of a shareholder class action against Woolworths, which includes a $4.73 million funding commission, but […]
Samsung Bioepis Australia has sued fellow biotechnology company Fresenius Kabi over a biosimilar of top selling immunosuppressant drug Humira, saying the invention ‘does not achieve […]
Several lenders have appealed a ruling that found they failed to prove steel giant Arrium falsified representations on loan drawdown notices ahead of its $2.8 […]
A former Greenwoods & Freehills partner will argue he is entitled to whistleblower protection in his lawsuit against the tax advisory firm and Lendlease, alleging […]
The settlement figure in a class action against a unit of Suncorp Group has been revealed as $33 million, and super members are set to […]
Trading firm Epoch Capital has brought proceedings against a quantitative analyst who allegedly downloaded confidential information from the firm’s computers. Epoch analyst Toby Carrodus has […]
Norton Rose Fulbright has lost the co-head of its energy, infrastructure and resources team in Australia to King & Wood Mallesons, just months after the […]
Korean drug company Samsung Bioepis has filed a second lawsuit seeking to invalidate German drug company Fresenius Kadi’s patent for a biosimilar of blockbuster arthritis […]
The law firm that lost the first ever application for a group costs order in class actions against ANZ and Westpac has indicated it will […]